Active Ingredient: PALONOSETRON HYDROCHLORIDE
Proprietary Name: PALONOSETRON HYDROCHLORIDE
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: EQ 0.25MG BASE/2ML (EQ 0.125MG BASE/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N207963
Product Number: 001
Approval Date: Aug 22, 2016
Applicant Holder Full Name: HIKMA PHARMACEUTICALS LLC
Marketing Status:
Discontinued
Patent and Exclusivity Information
